Page 81 - NATIONAL INSTITUTES OF HEALTH (NIH) GUIDELINES FOR CONDUCTING RESEARCH IN MINISTRY OF HEALTH (MOH) INSTITUTIONS & FACILITIES 3RD EDITION 2021
P. 81

F. INVESTIGATOR’S BROCHURE (IB)
                   21  Investigator’s Brochure    The content/format of  IB should follow section
                                                  7.5 (Appendix 2) page 71 Malaysian Guideline for
                      (The IB is a requirement for herbal   GCP 3rd edition

                                          t
                                        a
                                         l
                                           r
                                             s
                                            l
                                           i
                                           a
                                      i
                                      l
                      test item(s) going for c clinical trials)
                                        c
                                       i
                                      n

                                                 TITLE PAGE (Example)
                                                 TITLE OF STUDY
                                                   Sponsor’s Name:
                                                   Product:
                                                   Research Number:
                                                   Name(s) Chemical, Generic (if approved)
                                                   Trade Name(s) (if legally permissible and desired
                                                   by the sponsor)
                                                   Manufacturer:

                                                 INVESTIGATOR'S BROCHURE
                                                   Edition Number:
                                                   Release Date:
                                                   Replaces Previous Edition Number:
                                                   Date:

                                                 CONTENTS OF INVESTIGATOR'S BROCHURE
                                                 (Example)
                                                 CONFIDENTIALITY STATEMENT (optional)
                                                 SIGNATURE PAGE (optional)
                                                 TABLE OF CONTENTS
                                                 SUMMARY (preferably not exceeding two pages)
                                                 1.0 INTRODUCTION
                                                   1.1 References
                                                  2.0 PHYSICAL, CHEMICAL, AND PHARMACEUTICAL
                                                 PROPERTIES AND FORMULATION
                                                   2.1 Introduction
                                                   2.2 Product  description  (eg:  (invented) name of
                                                   medicinal  product, strength,  pharmaceutical
                                                   form)
                                                   2.3 Manufacturing of Product (eg: GMP
                                                   certificate)
                                                   2.4 Quality Control Tests (eg: In-Process Quality
                                                   Control (IPQC), Finished Product Quality Control
                                                   (FPQC))
                                                   2.5   Quality Assurance
                                                   2.6 Stability (eg: Container closure system,
                                                   storage condition, proposed shelf-life)
                                                   2.7 Attachments (may include certificate of
                                                   analysis)
                   NRDHM HERBAL TEST ITEM FOR  STUDIES Ver3.1 Mar2015                                              5








                                                  NIH Guidelines for Conducting Research in MOH, 2021  65
   76   77   78   79   80   81   82   83   84   85   86